…
kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. It also provides professional services, including consulting, training, process mapping, project management, and other services. kneat.com, inc. was founded in 2007 and is based in Limerick, Ireland.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Kneat.com Inc provides cloud-native validation lifecycle management software for regulated life-science companies, automating testing, documentation and compliance. Long-term growth could be supported by migration from on-premises to SaaS, persistent regulatory scrutiny, and cross-sell opportunities within pharma, biotech and contract research organizations, making its vertical focus and recurring revenues potentially attractive to investors.
Principal risks include execution challenges scaling enterprise sales, competition from larger and niche vendors, customer concentration and exposure to changes in regulatory spending.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -2.19M | -7.53M | -14.06M | -9.13M | -9.84M |
| Net income | -2.35M | -7.73M | -14.12M | -9.15M | -9.86M |
| Selling general administrative | 11.56M | 8.27M | 7.18M | 4.92M | 3.57M |
| Selling and marketing expenses | 22.74M | 17.16M | 13.80M | 8.52M | 3.78M |
| Gross profit | 34.70M | 36.76M | 23.13M | 14.65M | 9.32M |
| Reconciled depreciation | 13.99M | 10.13M | 7.40M | 5.70M | 4.40M |
| Ebit | -8.45M | -3.87M | -12.98M | -9.77M | -6.35M |
| Ebitda | 5.54M | 6.27M | -5.37M | -4.08M | -1.94M |
| Depreciation and amortization | 13.99M | 10.13M | 7.61M | 5.70M | 4.41M |
| Operating income | -8.45M | -5.95M | -13.53M | -9.77M | -6.35M |
| Other operating expenses | 71.71M | 54.89M | 47.76M | 33.52M | 21.86M |
| Interest expense | 3.43M | 3.67M | 1.08M | 0.23M | 0.28M |
| Tax provision | 0.16M | 0.19M | 0.06M | 0.02M | 0.02M |
| Interest income | 0.52M | 1.59M | 0.01M | 0.23M | 0.28M |
| Net interest income | -2.91M | -2.99M | -1.08M | -0.23M | -0.28M |
| Income tax expense | 0.16M | 0.19M | 0.06M | 0.02M | 0.02M |
| Total revenue | 63.26M | 48.94M | 34.22M | 23.75M | 15.50M |
| Total operating expenses | 43.15M | 42.71M | 36.74M | 24.43M | 15.67M |
| Cost of revenue | 28.56M | 12.18M | 11.09M | 9.09M | 6.18M |
| Total other income expense net | 6.26M | -1.59M | -0.53M | 0.64M | -3.48M |
| Net income from continuing ops | -2.35M | -7.73M | -14.12M | -9.15M | -9.86M |
| Net income applicable to common shares | - | -7.73M | -14.52M | -9.15M | -9.86M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 121.76M | 124.58M | 64.50M | 50.41M | 51.28M |
| Intangible assets | 45.73M | - | 27.64M | 19.36M | 13.44M |
| Other current assets | 1.79M | - | 1.14M | 0.93M | 0.50M |
| Total liab | 56.74M | 59.51M | 49.73M | 24.43M | 17.09M |
| Total stockholder equity | 65.02M | 65.07M | 14.76M | 25.98M | 34.19M |
| Other current liab | 8.81M | - | 6.48M | 4.77M | 2.77M |
| Common stock | 144.06M | - | 79.79M | 78.43M | 77.07M |
| Capital stock | 144.06M | 137.77M | 79.79M | 78.43M | 77.07M |
| Retained earnings | -81.38M | -79.03M | -70.45M | -56.33M | -47.18M |
| Other liab | - | - | - | 0.95M | 0.04M |
| Other assets | - | - | - | 1.10M | 1.22M |
| Cash | 48.74M | 58.89M | 15.25M | 12.28M | 21.56M |
| Total current liabilities | 36.12M | 34.76M | 22.06M | 16.97M | 10.19M |
| Current deferred revenue | 18.90M | - | 13.65M | 10.62M | 5.81M |
| Net debt | -13.70M | - | 12.92M | -5.19M | -13.70M |
| Short term debt | 7.87M | - | 0.54M | 0.59M | 0.99M |
| Short long term debt | 7.48M | 4.12M | - | - | 0.11M |
| Short long term debt total | 35.04M | - | 28.17M | 7.09M | 7.86M |
| Other stockholder equity | 7.30M | - | 5.25M | 3.45M | 3.05M |
| Property plant equipment | - | - | - | 7.81M | 8.48M |
| Total current assets | 65.64M | 79.14M | 27.99M | 22.13M | 28.14M |
| Net tangible assets | - | - | - | 6.62M | 20.74M |
| Net receivables | 15.11M | 12.33M | 11.60M | 8.91M | 6.08M |
| Long term debt | 14.06M | 19.04M | 21.66M | 0.00M | 0.00M |
| Accounts payable | 0.54M | 0.92M | 1.40M | 1.00M | 0.62M |
| Accumulated other comprehensive income | -4.96M | - | 0.17M | 0.43M | 1.25M |
| Non currrent assets other | 2.72M | - | 1.65M | 1.10M | 1.22M |
| Non current assets total | 56.12M | 45.44M | 36.50M | 28.28M | 23.14M |
| Capital lease obligations | 6.94M | 6.11M | 6.51M | 7.09M | 7.74M |
| Long term debt total | - | - | - | 6.50M | 6.86M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -17.52M | -16.77M | -11.91M | -10.04M |
| Change to liabilities | - | - | - | 7.56M | 4.57M |
| Total cashflows from investing activities | -20.10M | -17.52M | -15.97M | -11.91M | -10.04M |
| Net borrowings | -7.29M | -3.22M | 20.59M | -1.00M | -1.23M |
| Total cash from financing activities | -5.87M | 50.62M | 20.27M | -0.38M | 21.20M |
| Change to operating activities | - | - | - | - | 3.42M |
| Net income | -2.35M | -7.73M | -14.12M | -9.15M | -9.86M |
| Change in cash | -10.15M | 43.64M | 2.97M | -9.28M | 12.90M |
| Begin period cash flow | 58.89M | 15.25M | 12.28M | 21.56M | 8.66M |
| End period cash flow | 48.74M | 58.89M | 15.25M | 12.28M | 21.56M |
| Total cash from operating activities | 12.26M | 9.79M | -1.28M | 2.99M | 2.31M |
| Issuance of capital stock | 0.00M | 55.63M | 0.00M | 0.00M | 22.13M |
| Depreciation | 13.99M | 10.13M | 7.40M | 5.70M | 4.40M |
| Other cashflows from investing activities | 1.93M | -17.36M | 1.19M | 0.90M | 0.90M |
| Change to account receivables | 5.36M | -6.18M | -2.30M | -1.61M | -1.18M |
| Sale purchase of stock | - | 57.71M | 0.30M | 0.62M | 24.07M |
| Other cashflows from financing activities | -0.69M | -1.78M | -0.33M | 0.62M | 0.30M |
| Change to netincome | - | - | - | 0.50M | 4.33M |
| Capital expenditures | 0.28M | 19.88M | 17.16M | 12.82M | 10.04M |
| Change in working capital | 2.25M | 1.11M | 2.87M | 5.06M | 3.39M |
| Stock based compensation | 3.99M | 3.83M | 2.87M | 1.14M | 0.84M |
| Other non cash items | -1.63M | 2.26M | -0.35M | 0.24M | 3.53M |
| Free cash flow | 11.98M | -10.09M | -18.39M | -9.82M | -7.74M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VHI Vitalhub Corp |
0.12 1.54% |
7.91 | 81.40 | 40.65 | 4.72 | 1.94 | 3.65 | 23.34 |
| AIAI NetraMark Holdings Inc. |
0.02 3.64% |
0.57 | - | - | 513.40 | 71.64 | 504.87 | - |
kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. It also provides professional services, including consulting, training, process mapping, project management, and other services. kneat.com, inc. was founded in 2007 and is based in Limerick, Ireland.
| Name | Title | Year Born |
|---|---|---|
| Mr. Edmund Ryan | Co-Founder, CEO, Pres & Exec. Director | 1964 |
| Mr. Brian Ahearne | Co-Founder, Chief Information Officer & Company Sec. | 1969 |
| Mr. Kevin Fitzgerald | Co-founder, Chief Product Officer & Exec. Director | 1970 |
| Mr. Hugh Kavanagh | Chief Financial Officer | 1962 |
| Mr. Keith Holmes | Chief Technology Officer | NA |
| Ms. Laura Sweet | VP of Marketing | NA |
| Mr. Jacob Hahn Michelsen | Sr. VP of Global Sales | 1966 |
| Fiona McCarthy | Chief People & Culture Officer | NA |
| Mr. Edmund Ryan | Co-Founder, CEO, President & Executive Director | 1964 |
| Mr. Kevin Fitzgerald | Co-founder, Chief Product Officer & Executive Director | 1970 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.